Concepedia

Publication | Closed Access

iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7‐Dependent Pathway

DOI

26

Citations

12

References

2020

Year

Minxuan Xu, Chenxu Ge, Liancai Zhu, Yuting Qin, Chengjiang Du, Deshuai Lou, Qiang Li, Linfeng Hu, Yan Sun, Xianling Dai,
Hepatology

Abstract

iRhom2 may represent a therapeutic target for the treatment of HFD-induced hepatic steatosis and insulin resistance.

References

YearCitations

Page 1